FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2801382541> ?p ?o ?g. }

• W2801382541 endingPage "1416" @default.
• W2801382541 startingPage "1407" @default.
• W2801382541 abstract "In the pivotal Fracture Study in Postmenopausal Women with Osteoporosis (FRAME; NCT01575834), 1 year of the bone-forming agent romosozumab significantly reduced new vertebral and clinical fracture risk versus placebo. Nonvertebral fracture risk was not significantly reduced in the overall population, influenced by a low placebo-group fracture rate, observed particularly in the highest-enrolling region of Latin America. In year 1 of FRAME, postmenopausal women with a T-score of -2.5 to -3.5 at the total hip or femoral neck were randomized to subcutaneous romosozumab 210 mg or placebo once monthly for 12 months. Of 7180 randomized women, 43% were from Latin America, largely Colombia and Brazil. Prespecified analyses assessed fracture risk reductions by geographic regions. A significant treatment-by-geographic region interaction for the clinical (p = 0.029) and nonvertebral fracture (p = 0.042) endpoints led to further characterization of the Latin American population and comparison with the remaining study population, grouped post hoc as rest-of-world. Nonvertebral fracture efficacy in the overall population was also assessed by baseline fracture risk using the Fracture Risk Assessment Tool (FRAX). Romosozumab significantly and consistently reduced new vertebral fracture risk in Latin America (70% reduction; p = 0.014) and rest-of-world (74% reduction; p < 0.001). For nonvertebral fracture, risk reductions were observed in rest-of-world (42% reduction; p = 0.012), with no treatment effect observed in Latin America, where background nonvertebral fracture risk was low (1.2% in the placebo group). Consistent with this finding, in the overall population, greater reductions in nonvertebral fracture risk were observed among women with higher FRAX scores. These findings suggest that fracture risk assessment should consider regional factors in addition to classical risk factors, such as bone mineral density. In women at high risk for fracture, romosozumab reduced nonvertebral fracture risk within 1 year. © 2018 The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals, Inc." @default.
• W2801382541 created "2018-05-17" @default.
• W2801382541 creator A5008203290 @default.
• W2801382541 creator A5009972236 @default.
• W2801382541 creator A5011735451 @default.
• W2801382541 creator A5025806056 @default.
• W2801382541 creator A5026718897 @default.
• W2801382541 creator A5028056767 @default.
• W2801382541 creator A5037555787 @default.
• W2801382541 creator A5063460033 @default.
• W2801382541 creator A5083763741 @default.
• W2801382541 creator A5091416598 @default.
• W2801382541 date "2018-05-11" @default.
• W2801382541 modified "2023-10-15" @default.
• W2801382541 title "Romosozumab FRAME Study: A Post Hoc Analysis of the Role of Regional Background Fracture Risk on Nonvertebral Fracture Outcome" @default.
• W2801382541 cites W1830918957 @default.
• W2801382541 cites W1993035292 @default.
• W2801382541 cites W2022595186 @default.
• W2801382541 cites W2025881993 @default.
• W2801382541 cites W2032956576 @default.
• W2801382541 cites W2042352703 @default.
• W2801382541 cites W2044178924 @default.
• W2801382541 cites W2045787805 @default.
• W2801382541 cites W2065137888 @default.
• W2801382541 cites W2080822226 @default.
• W2801382541 cites W2096627331 @default.
• W2801382541 cites W2110022366 @default.
• W2801382541 cites W2124527463 @default.
• W2801382541 cites W2160005424 @default.
• W2801382541 cites W2161837912 @default.
• W2801382541 cites W2171709369 @default.
• W2801382541 cites W2335178464 @default.
• W2801382541 cites W2516614130 @default.
• W2801382541 cites W2520995084 @default.
• W2801382541 cites W2560833249 @default.
• W2801382541 cites W2754720807 @default.
• W2801382541 cites W2917781841 @default.
• W2801382541 cites W2987003872 @default.
• W2801382541 cites W4211100531 @default.
• W2801382541 cites W4254010767 @default.
• W2801382541 doi "https://doi.org/10.1002/jbmr.3439" @default.
• W2801382541 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29750828" @default.
• W2801382541 hasPublicationYear "2018" @default.
• W2801382541 type Work @default.
• W2801382541 sameAs 2801382541 @default.
• W2801382541 citedByCount "56" @default.
• W2801382541 countsByYear W28013825412018 @default.
• W2801382541 countsByYear W28013825412019 @default.
• W2801382541 countsByYear W28013825412020 @default.
• W2801382541 countsByYear W28013825412021 @default.
• W2801382541 countsByYear W28013825412022 @default.
• W2801382541 countsByYear W28013825412023 @default.
• W2801382541 crossrefType "journal-article" @default.
• W2801382541 hasAuthorship W2801382541A5008203290 @default.
• W2801382541 hasAuthorship W2801382541A5009972236 @default.
• W2801382541 hasAuthorship W2801382541A5011735451 @default.
• W2801382541 hasAuthorship W2801382541A5025806056 @default.
• W2801382541 hasAuthorship W2801382541A5026718897 @default.
• W2801382541 hasAuthorship W2801382541A5028056767 @default.
• W2801382541 hasAuthorship W2801382541A5037555787 @default.
• W2801382541 hasAuthorship W2801382541A5063460033 @default.
• W2801382541 hasAuthorship W2801382541A5083763741 @default.
• W2801382541 hasAuthorship W2801382541A5091416598 @default.
• W2801382541 hasBestOaLocation W28013825411 @default.
• W2801382541 hasConcept C126322002 @default.
• W2801382541 hasConcept C142724271 @default.
• W2801382541 hasConcept C1862650 @default.
• W2801382541 hasConcept C204787440 @default.
• W2801382541 hasConcept C27081682 @default.
• W2801382541 hasConcept C2775854910 @default.
• W2801382541 hasConcept C2776541429 @default.
• W2801382541 hasConcept C2776886416 @default.
• W2801382541 hasConcept C2777525943 @default.
• W2801382541 hasConcept C2778885795 @default.
• W2801382541 hasConcept C2908647359 @default.
• W2801382541 hasConcept C2994343686 @default.
• W2801382541 hasConcept C67761136 @default.
• W2801382541 hasConcept C71924100 @default.
• W2801382541 hasConcept C99454951 @default.
• W2801382541 hasConceptScore W2801382541C126322002 @default.
• W2801382541 hasConceptScore W2801382541C142724271 @default.
• W2801382541 hasConceptScore W2801382541C1862650 @default.
• W2801382541 hasConceptScore W2801382541C204787440 @default.
• W2801382541 hasConceptScore W2801382541C27081682 @default.
• W2801382541 hasConceptScore W2801382541C2775854910 @default.
• W2801382541 hasConceptScore W2801382541C2776541429 @default.
• W2801382541 hasConceptScore W2801382541C2776886416 @default.
• W2801382541 hasConceptScore W2801382541C2777525943 @default.
• W2801382541 hasConceptScore W2801382541C2778885795 @default.
• W2801382541 hasConceptScore W2801382541C2908647359 @default.
• W2801382541 hasConceptScore W2801382541C2994343686 @default.
• W2801382541 hasConceptScore W2801382541C67761136 @default.
• W2801382541 hasConceptScore W2801382541C71924100 @default.
• W2801382541 hasConceptScore W2801382541C99454951 @default.
• W2801382541 hasIssue "8" @default.
• W2801382541 hasLocation W28013825411 @default.
• W2801382541 hasLocation W28013825412 @default.
• W2801382541 hasOpenAccess W2801382541 @default.

• next